Name | triprolidine hydrochloride (anh.) |
---|---|
Synonyms |
EINECS 208-985-0
MFCD00039044 Triprolidine Hydrochloride Triprolidine HCl |
Description | Triprolidine is an oral active, first-generation histamine H1-receptor antagonist. Triprolidine can be used for the research of allergic rhinitis. triprolidine exhibits spinal motor and sensory block in rats[1][2][3]. |
---|---|
Related Catalog | |
Target |
H1 Receptor |
In Vivo | Triprolidine (292.81-1467.20 μg/kg; intrathecal injection) produces a dose-dependent effect of spinal motor and sensory block in rats[3]. Animal Model: Male Sprague-Dawley rat (300-350 g)[3] Dosage: 292.81 μg/kg, 488.02 μg/kg, 733.60μg/kg, 1098.83 μg/kg, 1467.20 μg/kg Administration: Intrathecal injection Result: Elicited a dose-dependent spinal block. |
References |
Density | 1.061g/cm3 |
---|---|
Boiling Point | 435.4ºC at 760mmHg |
Melting Point | 59-61ºC |
Molecular Formula | C19H23ClN2 |
Molecular Weight | 314.85200 |
Flash Point | 217.1ºC |
Exact Mass | 314.15500 |
PSA | 16.13000 |
LogP | 4.65740 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xn |
---|---|
Risk Phrases | 22-36/37/38 |
Safety Phrases | 26-36 |
RIDADR | UN 3249 |
WGK Germany | 3 |
RTECS | UT7658000 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2933990090 |
~51% 550-70-9 |
Literature: HIKAL LIMITED Patent: WO2009/84035 A1, 2009 ; Location in patent: Page/Page column 11-12 ; |
~% 550-70-9 |
Literature: WO2007/141803 A2, ; Page/Page column 6-7 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |